Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

QLGN Qualigen Therapeutics Inc

4,25

-0,09 (-2,07%)

25 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Qualigen Therapeutics (NASDAQ:QLGN)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Qualigen Therapeutics Charts.

Qualigen Therapeutics (NASDAQ:QLGN)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Qualigen Therapeutics Charts.

News Qualigen Therapeutics Inc

Form 8-K - Current report
Donnerstag 26 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Freitag 20 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dienstag 10 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
Donnerstag 5 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
Montag 25 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
Dienstag 19 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 8 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 1 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Qualigen Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen